Stoke Therapeutics, Inc.

NASDAQ:STOK

8.75 (USD) • At close May 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020201920182017
Operating Activities:
Net Income -88.981-104.699-101.067-85.805-52.243-32.325-12.521-5.558
Depreciation & Amortization 2.1772.4691.5460.9740.8880.450.2140.113
Deferred Income Tax 0000.1720.003000
Stock Based Compensation 27.4725.25722.85416.455.7681.9220.240.026
Change In Working Capital -28.14-6.0343.0230.0462.325-1.1051.0930.031
Accounts Receivables 00000000
Inventory 00000000
Accounts Payables 3.088-3.2080.1212.8975.2030.8911.7350.1
Other Working Capital -31.228-2.82242.902-2.851-2.878-1.9961.0930.031
Other Non Cash Items 0.6231.9361.7781.2561.0380.0030.010.004
Operating Cash Flow -86.851-81.067-31.866-66.907-42.221-31.055-10.964-5.384
Investing Activities:
Investments In Property Plant And Equipment -0.203-1.616-3.962-1.2-1.05-1.635-0.935-0.113
Acquisitions Net 0045.34475.22600.0010.010
Purchases Of Investments -167.2720-201.32-87.2260000
Sales Maturities Of Investments 60107.562159.4120000
Other Investing Activites 00-45.344-75.22600.0010.010
Investing Cash Flow -107.475105.946-45.882-76.426-1.05-1.634-0.925-0.113
Financing Activities:
Debt Repayment 00000000
Common Stock Issued 128.8452.08145.3441.286105.398151.912115.6412.975
Common Stock Repurchased 00000000
Dividends Paid 00000000
Other Financing Activities 2.2540.9261.0651.2842.71-2.15115.6395.974
Financing Cash Flow 131.09453.00746.4091.284108.108149.762115.6395.974
Other Information:
Effect Of Forex Changes On Cash 00000000
Net Change In Cash -63.23277.886-31.339-142.04964.837117.073103.750.477
Cash At End Of Period 128.779192.011114.125145.464287.513222.676105.6031.853